These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6826207)

  • 1. Biochemical studies of H-2K antigens from a group of related mutants. I. Identification of a shared mutation in B6-H-2bm5 and B6-H-2bm16.
    Yamaga KM; Pfaffenbach GM; Pease LR; McGovern D; Nisizawa T; Melvold RW; Kohn HI; Nathenson SG
    Immunogenetics; 1983; 17(1):19-29. PubMed ID: 6826207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical studies of H-2K antigens from a group of related mutants. II. Identification of a shared mutation in B6-H-2bm6, B6.C-H-2bm7, and B6.C-H-2bm9.
    Yamaga KM; Pfaffenbach GM; Pease LR; McGovern D; Nisizawa T; Melvold RW; Kohn HI; Nathenson SG
    Immunogenetics; 1983; 17(1):31-41. PubMed ID: 6826208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical studies on the H-2K antigens of the MHC mutants bm3 and bm11.
    Ewenstein BM; Uehara H; Nisizawa T; Melvold RW; Kohn HI; Nathenson SG
    Immunogenetics; 1980; 11(4):383-95. PubMed ID: 7429601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical studies on the H-2K mutant B6.C-H-2bm10.
    Pease LR; Ewenstein BM; McGovern D; Melvold RW; Nisizawa T; Nathenson SG
    Immunogenetics; 1983; 17(1):7-17. PubMed ID: 6826210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural differences between parent and mutant H-2K glycoproteins from two H-2K gene mutants: b6.c-h-2ba (Hzl) and B6-H-2bd (M505).
    Brown JL; Nathenson SG
    J Immunol; 1977 Jan; 118(1):98-102. PubMed ID: 830762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical studies on the H-2K antigens of the MHC mutant bml.
    Nisizawa T; Ewenstein BM; Uehara H; McGovern D; Nathenson SG
    Immunogenetics; 1981; 12(1-2):33-44. PubMed ID: 6782017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognition of H-2Kb mutant target cells by Moloney virus-specific cytotoxic T lymphocytes from bm13 (H-2Db-mutant) mice. II. Relationship of Kbm3 and Kbm11 in restriction specificities and allodeterminants.
    Stukart MJ; Boes J; Melief CJ
    J Immunol; 1984 Jul; 133(1):28-32. PubMed ID: 6202783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vivo activity of cytotoxic lymphocytes directed against the product of gene H-2Kb and its mutant alleles].
    Nikonenko BV; Pospelov LE
    Biull Eksp Biol Med; 1981 Apr; 91(4):479-80. PubMed ID: 7020792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical analysis of related, independently arising histocompatibility mutants: bm17 and KB-98 enlarge the "bg series" of H-2Kb mutants.
    Pfaffenbach GM; Melvold RW; Nathenson SG
    Biochem Genet; 1990 Aug; 28(7-8):433-41. PubMed ID: 2268259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid graft rejection between C57BL/6 and H-2Kb mutant mice. Differences in the immunogenic expression of the mutated molecule on thyroids of six different mutants.
    Isakov N; Bach FH
    Transplantation; 1983 Nov; 36(5):571-7. PubMed ID: 6356521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of two H-2Db mutants: B6. C-H-2bm13 and B6.C-H-2bm14.
    Morgan GM; Dellos H; McKenzie IF; Melvold RW; Bailey DW
    Immunogenetics; 1980; 11(4):341-9. PubMed ID: 6159320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of H-2Kb mutant mice. II. Definition of new H-2 specificities (H-2.68, 69, 71, 72) using the H-2Kb mutant, B6.C-H-2bm10.
    Morgan GM; McKenzie IF; Melvold RW
    Immunogenetics; 1980 Jul; 11(1):43-53. PubMed ID: 6160097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of H-2 mutations to quantitate alloreactivity: Alloreactivity is strongest against H-2 antigens which are closet to self.
    Pimsler M; Forman J
    Immunogenetics; 1980; 11(2):111-21. PubMed ID: 6967859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recognition of H-2Kb mutant target cells by Moloney virus-specific cytotoxic T lymphocytes from bm13 (H-2Db mutant) mice. I. Full recognition of Kbm11 by Kb-restricted CTL.
    Stukart MJ; Boes J; Melief CJ
    J Immunol; 1984 Jul; 133(1):24-7. PubMed ID: 6202782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of the mutated H-2Kbm1 antigen(s). Test of thyroid graft rejection between B6.C-H-2bm1 and C57BL/6 mice following reciprocal immunization with normal versus malignant cells.
    Isakov N; Segal S
    Immunobiology; 1983 Dec; 165(5):485-99. PubMed ID: 6363278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of H-2Kb mutant mice. I. Description and serological studies of B6.C-H-2bm9, -H-2bm10, and -H-2bm11.
    Morgan GM; McKenzie IF; Melvold RW
    Immunogenetics; 1980 Jul; 11(1):31-41. PubMed ID: 6160096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fine specificity of alloimmune cytotoxic T lymphocytes directed against H-2K. A study with Kb mutants.
    Melief CJ; de Waal LP; van der Meulen MY; Melvold RW; Kohn HI
    J Exp Med; 1980 May; 151(5):993-1013. PubMed ID: 6154770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B6.C-H-2bm12. A new H-2 mutation in the I region in the mouse.
    McKenzie IF; Morgan GM; Sandrin MS; Michaelides MM; Melvold RW; Kohn HI
    J Exp Med; 1979 Dec; 150(6):1323-38. PubMed ID: 159937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. H-2 gene control of resistance to P815-X2 mastocytoma.
    Kwak LW; Kucuk O; Melvold RW; Williams RM
    Cancer Res; 1983 Dec; 43(12 Pt 1):5754-7. PubMed ID: 6640527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NK-mediated elimination of mutant lymphocytes that have lost expression of MHC class I molecules.
    Kusunoki Y; Kyoizumi S; Honma M; Kubo Y; Ohnishi H; Hayashi T; Seyama T
    J Immunol; 2000 Oct; 165(7):3555-63. PubMed ID: 11034355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.